An outbreak of Herpes Rugbiorum managed by vaccination of players and sociosexual contacts

Journal of Infection

Volumn 33, Issue 3, 1996, Pages 163-167

  Skinner, G R B ^a   Davies, J ^a   Ahmad, A ^a   McLeish, P ^a   Buchan, A ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HERPES VACCINE;

ADOLESCENT; ADULT; ANIMAL CELL; ARTICLE; ATHLETE; CLINICAL ARTICLE; CONTROLLED STUDY; CORNEA; EYELID; HERPES VIRUS INFECTION; HUMAN; MALE; RUGBY; VACCINATION;

EID: 0029804378     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-4453(96)92129-5     Document Type: Article

References (17)

1. Verbev J, Lowe NJ. Herpes Rugbiorum. Lancet 1974; 2: 1523-1524.
2. More JB, Keyser MJ, Becker WB. Traumatiese Herpesvirus hominis-infectore tydens rugby (Herpes Venotorum). SA Medieve Tydscrif 1978; 54: 752-754.
3. Shute P, Jeffries DJ, Maddocks AC. Scrumpox caused by herpes Simplex virus. BMJ 1979; II: 1629.
4. White WB, Grantkels JJM. Transmission of Herpes simplex virus type-1 infection in rugby players. JAMA 1984; 252: 533-535.
5. MacPherson I, Stoker M. Polyoma transformation of hamster cell clones - an investigation of genetic factors affecting cell competence. Virology 1962; 16: 147.
6. Geder L. Skinner GRB. Difference in the properties of thymidine kinase produced in cells infected with type 1 and type 2 herpes virus. J Gen Virol 1971; 12: 195-197.
7. Harper L, Bedson HS, Buchan A. Identification of orthopoxviruses by polyacrylamide gel electrophoresis of intracellular polypeptides 1. Four major groupings. Virology 1979; 93: 435-444.
8. Skinner GRB, Fink C, Melling J. et al. Report of twelve years experience in open study of Skinner herpes simplex vaccine towards prevention of herpes genitalis. Med Microbiol Immunol 1992; 180: 305-320.
9. Skinner GRB. Chemotherapeutic and immunotherapeutic management of herpes genitalis. Curr Obstetr Gynaecol 1993; 3: 225-231.
10. Dorman JM. Scrum strep. NEJM 1981; 305: 467.
11. Kern AB, Schiff BL. Vaccine therapy in recurrent herpes simplex. Dermatalogica 1964; 89: 844-845.
12. Kutinova L, Benda R, Kaloz Z. et al. Placebo-controlled study with subunit herpes simplex virus vaccine in subjects suffering from frequent herpetic recurrences. Vaccine 1988; 6: 223-228.
13. Mullin WB. Cited in Hull RN, Peck FB. Vaccination against herpesvirus infections. Proc of 1st Int Cong Vaccines against viral and reckettsial dis Man 1967; 147: 266-275.
14. Cappel R, Sprecher S, DeCuyper F, DeBraekeleer J. Clinical efficacy of a herpes simplex subunit vaccine. J Med Virol 1985; 16: 137-145.
15. Strauss SE, Corey L, Burke RL. et al. Placebo-controlled trial of vaccination with recombinant glycoprotein D of herpes simplex type 2 for immunotherapy of genital herpes. Lancet 1994; 343: 1460-1464.
16. - )MRC5 administered following an initial clinical episode towards prevention of herpes genitalis. Br J Ven Dis 1983; 59: 311-313.
17. -)MRC], for the modulation of frequently recurrent genital herpes: report of a prospective double blind placebo-controlled trial. Submitted for publication.